[February 14, 2012]

ARIAD to Webcast Conference Call on Fourth Quarter and Year-End 2011 Financial Results

ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will host a live webcast of its quarterly conference call at 8:30 a.m. (ET) on Tuesday, February 28, 2012. Harvey J. Berger, M.D., chairman and chief executive officer, will host the call. Senior management will discuss the Company's financial results as of December 31, 2011, key corporate objectives and additional corporate activities. The Company will announce the highlights of these topics in a press release to be issued before the market opens on February 28, 2012 prior to the conference call.

The live webcast can be accessed by visiting the investor relations section of the Company's website at http://investor.ariad.com. The call can be accessed by dialing 866-700-0133 (domestic) or 617-213-8831 (international) five minutes prior to the start time and providing the pass code 24601830. A replay of the call will be available on the ARIAD website approximately two hours after completion of the call and will be archived for three weeks.

About ARIAD

ARIAD Pharmaceuticals, Inc. is an emerging global oncology company focused on the discovery, development and commercialization of medicines to transform the lives of cancer patients. ARIAD's approach to structure-based drug design has led to three internally discovered, molecularly targeted product candidates for drug-resistant and difficult-to-treat cancers, including certain forms of chronic myeloid leukemia, soft tissue and bone sarcomas and non-small cell lung cancer. For additional information, visit http://www.ariad.com.

[ Back To TMCnet.com's Homepage ]